从免疫疗法到液体活检 肺癌治疗今年取得了哪些突破?(3)
2020-05-15 未知 admin
[2] European Commission approves Roche’s new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer. Retrieved December 2, 2019, from https://www.roche.com/media/releases/med-cor-2019-09-06.htm
[3] Year in Review: Lung Cancer. New regimens, strategies, but immunotherapy continues domination. Retrieved December 2, 2019, from https://www.medpagetoday.com/hematologyoncology/lungcancer/83163
*声明:本文由入驻新浪医药新闻作者撰写,观点仅代表作者本人,不代表新浪医药新闻立场。▽关注【药明康德】微信公众号
鐑瘝锛